Market Tracker

12/19 6:05pm ET

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

2.53
Data as of Dec 19
 -0.05 / -1.94%
Today’s Change
1.00
Today|||52-Week Range
8.46
-46.62%
Year-to-Date
No recent news for Sunesis Pharmaceuticals Inc.

Today’s Trading

Previous close2.58
Today’s open2.57
Day’s range2.51 - 2.64
Volume1,668,223
Average volume (3 months)2,853,636
Market cap$156.7M
Dividend yield--
Data as of 3:59pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)+27.47%
Earnings growth (this year)-34.09%
Earnings growth (next 5 years)--
Revenue growth (last year)+111.93%
P/E ratioNM
Price/Sales31.13
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RLMDRelmada Therapeutics...0.000.00%
GLYCGlycoMimetics Inc-0.42-4.64%
CRMECardiome Pharma Corp-0.09-0.99%
NNVCNanoViricides Inc-0.14-4.71%
Data as of 4:08pm ET, 12/19/2014

Financials

Next reporting dateMarch 11, 2015
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$8.0M
Annual profit (last year)-$34.6M
Net profit margin-434.87%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel N. Swisher
CFO, Secretary &
EVP-Corporate Development
Eric H. Bjerkholt
Corporate headquarters
South San Francisco, California

Forecasts